COLPAL:NSE:NSE- (INR)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 2801.9

Change

-29.25 (-1.03)%

Market Cap

USD 770.41B

Volume

0.33M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
HINDUNILVR:NSE Hindustan Unilever Limited

N/A

USD 5,736.18B
GODREJCP:NSE Godrej Consumer Products Limit..

N/A

USD 1,387.81B
DABUR:NSE Dabur India Limited

N/A

USD 1,064.89B
MARICO:NSE Marico Limited

N/A

USD 788.48B
PGHH:NSE Procter & Gamble Hygiene and H..

N/A

USD 526.56B
EMAMILTD:NSE Emami Limited

N/A

USD 306.45B
GILLETTE:NSE Gillette India Limited

N/A

USD 245.59B
JYOTHYLAB:NSE Jyothy Labs Limited

N/A

USD 163.50B
BAJAJCON:NSE Bajaj Consumer Care Limited

N/A

USD 37.69B
CUPID:NSE Cupid Limited

N/A

USD 24.46B

ETFs Containing COLPAL:NSE

INCO Columbia India Consumer E.. 0.00 % 0.77 %

N/A

USD 0.33B
RXD-U:CA 0.00 % 0.00 %

N/A

N/A
RXD:CA RBC Quant Emerging Market.. 0.00 % 0.77 %

N/A

CAD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.70% 63% D 52% F
Dividend Return 0.40% 25% F 38% F
Total Return 13.10% 63% D 52% F
Trailing 12 Months  
Capital Gain 65.96% 80% B- 65% D
Dividend Return 1.90% 83% B 79% B-
Total Return 67.86% 80% B- 66% D+
Trailing 5 Years  
Capital Gain 148.46% 86% B+ 46% F
Dividend Return 13.83% 91% A- 80% B-
Total Return 162.29% 86% B+ 47% F
Average Annual (5 Year Horizon)  
Capital Gain 16.38% 53% F 26% F
Dividend Return 18.56% 60% D- 28% F
Total Return 2.18% 92% A 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.36% 60% D- 83% B
Risk Adjusted Return 73.17% 80% B- 61% D-
Market Capitalization 770.41B 73% C 94% A

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector